CPEZAQ
RegisteredWord Mark
•
Ownership
GG
Owner Name
Type: Organization / Private Company Limited by Shares
Address
GSK Medicines Research Centre, Gunnels Wood Road
Stevenage, SG12NY
United Kingdom
Critical Dates
First Use Date
Not filed yet
Filing Date
Apr 30, 2025
Registration Date
Dec 30, 2025
Mark Descriptions
Goods
Class 5
Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the prevention of infectious diseases...
Mark Elements
Text Mark
CPEZAQ
Category
Trademark
Standard Characters
Yes
Color Claim
No
Data source: USPTO TSDR
View on USPTO websiteTrademark Timeline
Filing Date
Publication Date
Registration Date
USPTO Records
Title | Date | Category | Source | Pages | Format | Actions |
|---|---|---|---|---|---|---|
Notice of Registration Email ERO(31 KB) | Dec 30, 2025 | Unknown | CMS | 1 | XML | |
Registration Certificate ORC(302 KB) | Dec 30, 2025 | Outgoing | CMS | 1 | PDF | |
OG Publication Confirmation PB3(30 KB) | Nov 11, 2025 | Unknown | CMS | 1 | XML | |
Notification of Notice of Publication EB4(22 KB) | Nov 5, 2025 | Unknown | CMS | 1 | XML | |
Notice of Publication PB1(30 KB) | Nov 5, 2025 | Unknown | CMS | 1 | XML | |
TRAM Snapshot of App at Pub for Oppostn (Part 1) PST(38 KB) | Oct 10, 2025 | Unknown | CMS | 2 | XML | |
TRAM Snapshot of App at Pub for Oppostn (Part 2) PST(38 KB) | Oct 10, 2025 | Unknown | CMS | 2 | PNG | |
XSearch Search Summary XSS(6 KB) | Sep 25, 2025 | XSearch | CMS | 1 | PDF | |
Application (Part 1) APP(21 KB) | Apr 30, 2025 | Unknown | CMS | 3 | XML | |
Application (Part 2) APP(21 KB) | Apr 30, 2025 | Unknown | CMS | 3 | JPEG | |
Application (Part 3) APP(21 KB) | Apr 30, 2025 | Unknown | CMS | 3 | PDF |
AI AssessmentCached Mar 12, 2026, 11:51 AMCached
AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.
Trademark Summary
The mark CPEZAQ is a standard character trademark covering pharmaceutical preparations in International Class 005, including vaccines, anti-infectives, and treatments for damaged skin and tissue, pain, inflammation, obesity, infectious diseases, and various viral, metabolic, endocrine, musculoskeletal, cardiovascular, and other diseases and disorders, as well as goods/services in domestic classes 006, 018, 044, 046, 051, and 052. It is owned by Glaxo Group Limited, a UK-based private company limited by shares located at GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY. The mark is registered on the Principal Register with registration number 8085191 effective December 30, 2025, based on a UK priority registration (UK00003286499). No active oppositions or legal proceedings are present.
Recent Activity
Filed on April 30, 2025, the application proceeded quickly through examination, was approved for publication on October 10, 2025, and published for opposition on November 11, 2025. It registered on the Principal Register on December 30, 2025, with confirmation emailed the same day.
USPTO
AI Analysis
v2.8.0
Never miss important updates for this trademark
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach